TrumpRx.gov Launches: President Trump Offers Big Savings to Millions of Americans
President Donald J. Trump recently launched TrumpRx.gov, a groundbreaking platform that aims to reduce prescription drug costs for millions of Americans. This initiative marks a significant shift in how Americans access affordable medications, emphasizing transparency and cost-effectiveness.
Big Savings on Prescription Drugs
TrumpRx.gov offers Americans direct access to lower prices on a variety of commonly used, high-cost brand-name drugs. Leveraging Most-Favored-Nation pricing agreements with top pharmaceutical manufacturers, the program ensures that U.S. prices are competitive with the lowest in other developed countries.
Immediate Relief for Patients
Beginning today, American patients—particularly those who encounter high out-of-pocket expenses for prescriptions not entirely covered by insurance—can benefit from notable price reductions on essential medications.
Example Price Reductions
- GLP-1 Medications: Prices for Ozempic® drop from $1,028 to an average of $350, and Wegovy® injectable prices decrease from $1,349 to as low as $199.
- Wegovy® Pill: Monthly prices fall from $1,349 to as low as $149.
- Zepbound®: Prices decrease from $1,088 to an average of $346.
Fertility Drug Savings
Many Americans facing infertility often pay for treatments out-of-pocket. With TrumpRx.gov, savings can average over $2,000 per treatment cycle. Significant price reductions include:
- Gonal-F®: As low as $168 per pen.
- Cetrotide®: Reduced from $316 to $22.50.
- Ovidrel®: Prices drop from $251 to $84.
The Road Ahead for TrumpRx.gov
This launch represents just the beginning for TrumpRx.gov. The Trump Administration plans to onboard additional pharmaceutical companies that have Most-Favored-Nation agreements. As they strive for broader participation, the platform will aim to increase savings for American consumers.
Call for Legislative Support
For those obtaining prescriptions through insurance, President Trump urges Congress to promptly enact his Great Healthcare Plan. This proposed legislation seeks to codify the savings from the Most-Favored-Nation initiative, reduce insurance premiums, and hold insurance companies accountable.
Furthermore, the plan aims to enhance price transparency and allow for the inclusion of TrumpRx.gov purchases in health plans, ultimately ensuring that all Americans can benefit from historic decreases in drug costs.
